“BioTime Licenses Beckman Research Institute of City of Hope to Manufacture Clinical Grade Stem Cells ALAMEDA, Calif.--(BUSINESS WIRE)--Apr. 22, 2015-- BioTime, Inc. (NYSE MKT: BTX) today announced a nonexclusive License Agreement between BioTime’s subsidiary ES Cell International Pte Ltd (ESI)

frothmouth のブックマーク 2015/04/23 00:48

<blockquote class="hatena-bookmark-comment"><a class="comment-info" href="https://b.hatena.ne.jp/entry/248318269/comment/frothmouth" data-user-id="frothmouth" data-entry-url="https://b.hatena.ne.jp/entry/investor.biotimeinc.com/phoenix.zhtml?c=83805&p=irol-newsArticle&id=2038690" data-original-href="http://investor.biotimeinc.com/phoenix.zhtml?c=83805&p=irol-newsArticle&id=2038690" data-entry-favicon="https://cdn-ak2.favicon.st-hatena.com/64?url=http%3A%2F%2Finvestor.biotimeinc.com%2Fphoenix.zhtml%3Fc%3D83805%26p%3Dirol-newsArticle%26id%3D2038690" data-user-icon="/users/frothmouth/profile.png">http://investor.biotimeinc.com/phoenix.zhtml?c=83805&p=irol-newsArticle&id=2038690</a><br><p style="clear: left">“BioTime Licenses Beckman Research Institute of City of Hope to Manufacture Clinical Grade Stem Cells ALAMEDA, Calif.--(BUSINESS WIRE)--Apr. 22, 2015-- BioTime, Inc. (NYSE MKT: BTX) today announced a nonexclusive License Agreement between BioTime’s subsidiary ES Cell International Pte Ltd (ESI) </p><a class="datetime" href="https://b.hatena.ne.jp/frothmouth/20150423#bookmark-248318269"><span class="datetime-body">2015/04/23 00:48</span></a></blockquote><script src="https://b.st-hatena.com/js/comment-widget.js" charset="utf-8" async></script>

このブックマークにはスターがありません。
最初のスターをつけてみよう！

http://investor.biotimeinc.com/phoenix.zhtml?c=83805&p=irol-newsArticle&id=2038690

investor.biotimeinc.com2015/04/23

1 人がブックマーク・1 件のコメント

他のコメントを読む

＼コメントがサクサク読めるアプリです／

はてなブックマーク

http://investor.biotimeinc.com/phoenix.zhtml?c=83805&p=irol-newsArticle&id=2038690

はてなブックマーク

公式Twitter

はてなのサービス